Voglibose, an alpha-glucosidase inhibitor, inhibits the breakdown of disaccharides into monosaccharides by acting competitively on the activities of an alpha-glucosidase, controlling postprandial hyperglycemia [26, 27]. The gene discussed is GAA; the disease is Hyperglycemia.